What Does The Industry Outlook Reveal About Revenue And CAGR Projections For The Drug-Coated Balloons Global Market Report 2025 Market Through 2029?

 What Are The Estimated Market Size And CAGR For The Drug-Coated Balloons Global Market Report 2025 Market Between 2025 And 2029?

 The drug-coated balloons market size has grown rapidly in recent years. It will grow from $1.08 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (pad), reducing restenosis rates, advancements in interventional cardiology.

 
 The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $2.2 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives. Major trends in the forecast period include regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp
 
 What Essential Growth Drivers Are Pushing The Drug-Coated Balloons Global Market Report 2025 Market Forward?
 The rise in the prevalence of coronary artery disease is expected to propel the growth of the drug-coated balloons market going forward. Coronary artery disease (CAD) is a medical condition defined by the narrowing or obstruction of the coronary arteries, that feed blood to the heart muscle, leading to heart attacks. The drug-coated balloon is a medical device used in the treatment of coronary artery disease. The drug is released into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery after angioplasty. For instance, in August 2022, according to a study published in the Journal of the American College of Cardiology, a US-based organization, all four cardiovascular risk factors are anticipated to rise among the general U.S. population between 2025 and 2060, with diabetes showing the biggest percentage increase of 39.3%, followed by dyslipidemia with an increase of 27.6%, hypertension with an increase of 25.1%, and obesity with an increase of 18.3%. The researchers discovered that heart failure (33.4%) and ischemic heart disease (30.7%) had the biggest anticipated increases in rates, followed by heart attack (16.9%) and stroke (33.8%). Therefore, the rise in the prevalence of coronary artery disease is expected to boost the drug-coated balloon market. 
 
 Which Segment Groups Play A Crucial Role In Outlining The Drug-Coated Balloons Global Market Report 2025 Market’s Structure?
 The drug-coated balloonsmarket covered in this report is segmented — 
 
 1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications
 2) By Drug Type: Paclitaxel, Sirolimus
 3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers
 
 Subsegments:
 1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons
 2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons
 3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications
 
 Which Trends Are Expected To Steer The Evolution Of The Drug-Coated Balloons Global Market Report 2025 Market?
 Product innovations are a key trend gaining popularity in the drug-coated balloon market. Major companies operating in the drug-coated balloon market are focused on developing new technological and innovative solutions to strengthen their position in the market. For instance, in August 2022, Becton, Dickinson, and Company (BD), a US-based medical technology company, launched the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB). This trial aims to assess the safety and effectiveness of the sirolimus DCB in treating patients with peripheral artery disease, a condition that significantly impacts mobility and quality of life. 
 
 Which Companies Represent The Key Strategic Forces Within The Drug-Coated Balloons Global Market Report 2025 Market?
 Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed 
 
 Get Your In-Depth Drug-Coated Balloons Global Market Report 2025 Market Report Now:
 https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report
 
 What Are The Fastest-Expanding Regions Contributing To The Growth Of The Drug-Coated Balloons Global Market Report 2025 Market?
 North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company